Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

about

Rapid customised operon assembly by yeast recombinational cloning.Living functional hydrogels generated by bioorthogonal cross-linking reactions of azide-modified cells with alkyne-modified polymers.Improving Immunotherapy Through Glycodesign

P2860

Q40285768-5907570E-3E0F-4108-AF16-BD35EA4E9B20 Q55259533-79D8F924-BA7B-478D-99FF-C8ED441FC741 Q59132146-03AE8278-A120-4110-B6CF-72D5DB8C7528

P2860

Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

Item

http://www.wikidata.org/entity/Q38452524

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Metabolic glycoengineering bac ...... olite production applications.

@en

type

Item

label

Metabolic glycoengineering bac ...... olite production applications.

@en

prefLabel

Metabolic glycoengineering bac ...... olite production applications.

@en

P1476

Metabolic glycoengineering bac ...... olite production applications.

@en

P2093

Christopher T Saeui

http://www.w3.org/2001/XMLSchema#string

Esteban Urias

http://www.w3.org/2001/XMLSchema#string

Kevin J Yarema

http://www.w3.org/2001/XMLSchema#string

Lingshu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Cell surface engineering by a modified Staudinger reaction

Addition of a photocrosslinking amino acid to the genetic code of Escherichiacoli.

Expanding the genetic code

Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis

Metabolic Engineering of a Pentose Metabolism Pathway in Ethanologenic Zymomonas mobilis

Archaeal flagella, bacterial flagella and type IV pili: a comparison of genes and posttranslational modifications

The human microbiome: at the interface of health and disease

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Modulation of protein structure and function by asparagine-linked glycosylation.

Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.

P2888

s10719-015-9583-9

P304

425-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10719-015-9583-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mohit P Mathew

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038320357

http://www.w3.org/2001/XMLSchema#string

P698

25931032

http://www.w3.org/2001/XMLSchema#string

P932

5753405

http://www.w3.org/2001/XMLSchema#string

Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

about

P2860

P2860

Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932